These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 28978015)
41. Evidence for free radical generation due to NADH oxidation by aldehyde oxidase during ethanol metabolism. Mira L; Maia L; Barreira L; Manso CF Arch Biochem Biophys; 1995 Apr; 318(1):53-8. PubMed ID: 7726572 [TBL] [Abstract][Full Text] [Related]
42. The effect of p-(chloromercuri)benzoate modification of cytosolic aldehyde dehydrogenase from sheep liver. Evidence for a second aldehyde binding site. Hill JP; Motion RL; Buckley PD; Blackwell LF Arch Biochem Biophys; 1994 Apr; 310(1):256-63. PubMed ID: 8161214 [TBL] [Abstract][Full Text] [Related]
43. Reduction of an aldehyde by a NADH/Zn2+ -dependent redox active ribozyme. Tsukiji S; Pattnaik SB; Suga H J Am Chem Soc; 2004 Apr; 126(16):5044-5. PubMed ID: 15099068 [TBL] [Abstract][Full Text] [Related]
44. Omeprazole as a potent activator of human cytosolic aldehyde dehydrogenase ALDH1A1. Calleja LF; Belmont-Díaz JA; Medina-Contreras O; Quezada H; Yoval-Sánchez B; Campos-García J; Rodríguez-Zavala JS Biochim Biophys Acta Gen Subj; 2020 Jan; 1864(1):129451. PubMed ID: 31678145 [TBL] [Abstract][Full Text] [Related]
45. Targeted therapy for a subset of acute myeloid leukemias that lack expression of aldehyde dehydrogenase 1A1. Gasparetto M; Pei S; Minhajuddin M; Khan N; Pollyea DA; Myers JR; Ashton JM; Becker MW; Vasiliou V; Humphries KR; Jordan CT; Smith CA Haematologica; 2017 Jun; 102(6):1054-1065. PubMed ID: 28280079 [TBL] [Abstract][Full Text] [Related]
46. [Expression changes of aldehyde dehydrogenase 1A1 in rat cryptorchidism and normal testis]. Qian Y; Hong L; Chen YH; Ge WL; Yin QY; Xian H Zhonghua Yi Xue Za Zhi; 2016 Sep; 96(34):2744-2748. PubMed ID: 27667110 [No Abstract] [Full Text] [Related]
47. Aldehyde dehydrogenase 1A1 circumscribes high invasive glioma cells and predicts poor prognosis. Xu SL; Liu S; Cui W; Shi Y; Liu Q; Duan JJ; Yu SC; Zhang X; Cui YH; Kung HF; Bian XW Am J Cancer Res; 2015; 5(4):1471-83. PubMed ID: 26101711 [TBL] [Abstract][Full Text] [Related]
48. Discovery of coumarin-based selective aldehyde dehydrogenase 1A1 inhibitors with glucose metabolism improving activity. Liang D; Fan Y; Yang Z; Zhang Z; Liu M; Liu L; Jiang C Eur J Med Chem; 2020 Feb; 187():111923. PubMed ID: 31816557 [TBL] [Abstract][Full Text] [Related]
49. Tungsten Enzyme Using Hydrogen as an Electron Donor to Reduce Carboxylic Acids and NAD Winiarska A; Hege D; Gemmecker Y; Kryściak-Czerwenka J; Seubert A; Heider J; Szaleniec M ACS Catal; 2022 Jul; 12(14):8707-8717. PubMed ID: 35874620 [TBL] [Abstract][Full Text] [Related]
50. How to conjugate the stemness marker ALDH1A1 with tumor angiogenesis, progression, and drug resistance. Ciccone V; Morbidelli L; Ziche M; Donnini S Cancer Drug Resist; 2020; 3(1):26-37. PubMed ID: 35582039 [TBL] [Abstract][Full Text] [Related]
51. DKK1 maintained cancer stem-like properties of esophageal carcinoma cells via ALDH1A1/SOX2 axis. Lu Z; Zhou C; Hu J; Xiong L; Cong Z; Shen Y Int J Clin Exp Pathol; 2017; 10(9):9489-9495. PubMed ID: 31966823 [TBL] [Abstract][Full Text] [Related]
52. Silencing of NRF2 Reduces the Expression of ALDH1A1 and ALDH3A1 and Sensitizes to 5-FU in Pancreatic Cancer Cells. Duong HQ; You KS; Oh S; Kwak SJ; Seong YS Antioxidants (Basel); 2017 Jul; 6(3):. PubMed ID: 28671577 [TBL] [Abstract][Full Text] [Related]
53. How Does Anand G; Waiger D; Vital N; Maman J; Ma LJ; Covo S Front Microbiol; 2019; 10():329. PubMed ID: 30873138 [TBL] [Abstract][Full Text] [Related]
54. Scaffold hopping based designing of selective ALDH1A1 inhibitors to overcome cyclophosphamide resistance: synthesis and biological evaluation. Narendra G; Raju B; Verma H; Kumar M; Jain SK; Tung GK; Thakur S; Kaur R; Kaur S; Sapra B; Silakari O RSC Med Chem; 2024 Jan; 15(1):309-321. PubMed ID: 38283216 [TBL] [Abstract][Full Text] [Related]
55. Evaluation of quercetin as a potential cytoprotector against acetaldehyde using the cultured hepatocyte model with aldehyde dehydrogenase isozyme deficiency. Xu Y; Sawamoto T; Sun R; Ishikura A; Munemasa S; Murata Y; Satoh A; Matsumoto A; Nakamura T; Nakamura Y Biosci Biotechnol Biochem; 2024 Sep; 88(10):1199-1202. PubMed ID: 38991992 [TBL] [Abstract][Full Text] [Related]
56. Targeting ALDH1A1 to induce Necroptosis in Nasopharyngeal Carcinoma. Wang H; Zhan Y; Peng S; Fan S; Wang W J Cancer; 2022; 13(14):3515-3525. PubMed ID: 36484016 [TBL] [Abstract][Full Text] [Related]
57. Expression of aldehyde dehydrogenase family 1 member A1 and high mobility group box 1 in oropharyngeal squamous cell carcinoma in association with survival time. Qian X; Coordes A; Kaufmann AM; Albers AE Oncol Lett; 2016 Nov; 12(5):3429-3434. PubMed ID: 27900016 [TBL] [Abstract][Full Text] [Related]